Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Wade

Showing results (71-80 of 208) with videos related to

Pageof 21
Sort By:
Annals of the New York Academy of Sciences|May 7, 2009
Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3Roger J Summers, Ross A D Bathgate, John D Wade, et al.
International Journal of Antimicrobial Agents|October 1, 2013
Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureusEszter Ostorhazi, Elvira Voros, Eva Nemes-Nikodem, et al.
Amino Acids|August 22, 2014
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteriaWenyi Li, Julien Tailhades, Neil M O'Brien-Simpson, et al.
Peptides|August 30, 2008
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibioticsMarco Cassone, Paraskevi Vogiatzi, Raffaele La Montagna, et al.
The FEBS Journal|August 14, 2009
Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3Xiao Luo, Ross A D Bathgate, Ya-Li Liu, et al.
British Journal of Pharmacology|December 7, 2016
Relaxin family peptides: structure-activity relationship studiesNitin A Patil, K Johan Rosengren, Frances Separovic, et al.
Annals of the New York Academy of Sciences|May 7, 2009
RXFP1 couples to the Galpha-Gbetagamma-PI3K-PKCzeta pathway via the final 10 amino acids of the receptor C-terminal tailMichelle L Halls, Maria Papaioannou, John D Wade, et al.
Biomed Research International|February 17, 2015
Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stabilityVinojini B Nair, Ross A D Bathgate, Frances Separovic, et al.
The Journal of Biological Chemistry|March 21, 2006
Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivoMark P Del Borgo, Richard A Hughes, Ross A D Bathgate, et al.
Biochimica Et Biophysica Acta|June 19, 2007
Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42)Tong-Lay Lau, John D Gehman, John D Wade, et al.
Pageof 21

Showing results (71-80 of 208) with videos related to

Sort By:
Pageof 21
Annals of the New York Academy of Sciences|May 7, 2009
Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3Roger J Summers, Ross A D Bathgate, John D Wade, et al.
International Journal of Antimicrobial Agents|October 1, 2013
Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureusEszter Ostorhazi, Elvira Voros, Eva Nemes-Nikodem, et al.
Amino Acids|August 22, 2014
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteriaWenyi Li, Julien Tailhades, Neil M O'Brien-Simpson, et al.
Peptides|August 30, 2008
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibioticsMarco Cassone, Paraskevi Vogiatzi, Raffaele La Montagna, et al.
The FEBS Journal|August 14, 2009
Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3Xiao Luo, Ross A D Bathgate, Ya-Li Liu, et al.
British Journal of Pharmacology|December 7, 2016
Relaxin family peptides: structure-activity relationship studiesNitin A Patil, K Johan Rosengren, Frances Separovic, et al.
Annals of the New York Academy of Sciences|May 7, 2009
RXFP1 couples to the Galpha-Gbetagamma-PI3K-PKCzeta pathway via the final 10 amino acids of the receptor C-terminal tailMichelle L Halls, Maria Papaioannou, John D Wade, et al.
Biomed Research International|February 17, 2015
Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stabilityVinojini B Nair, Ross A D Bathgate, Frances Separovic, et al.
The Journal of Biological Chemistry|March 21, 2006
Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivoMark P Del Borgo, Richard A Hughes, Ross A D Bathgate, et al.
Biochimica Et Biophysica Acta|June 19, 2007
Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42)Tong-Lay Lau, John D Gehman, John D Wade, et al.
Pageof 21